medroxyprogesterone acetate

FDA Drug Profile — Provera, Depo-SubQ Provera, medroxyprogesterone acetate, Depo-Provera, Medroxyprogesterone Acetate Injectable Suspension

medroxyprogesterone acetate is listed in the FDA National Drug Code directory with 22 NDC codes, marketed under brand names including Provera, Depo-SubQ Provera, medroxyprogesterone acetate. Available dosage forms: tablet, injection, suspension, powder.

Drug Details

Generic Name
medroxyprogesterone acetate
Brand Names
Provera, Depo-SubQ Provera, medroxyprogesterone acetate, Depo-Provera, Medroxyprogesterone Acetate Injectable Suspension
Application Number
NDA011839
Sponsor
Pharmacia & Upjohn Company LLC
NDC Codes
22
Dosage Forms
TABLET, INJECTION, SUSPENSION, POWDER
Routes
ORAL, SUBCUTANEOUS, INTRAMUSCULAR
Active Ingredients
MEDROXYPROGESTERONE ACETATE

Indications and Usage

1 INDICATIONS AND USAGE PREMPRO/PREMPHASE is an estrogen plus progestin indicated in a woman with a uterus for: • Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause ( 1.1 ) • Treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause ( 1.2 ) • Prevention of Postmenopausal Osteoporosis ( 1.3 ) 1.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause 1.2 Treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause 1.3 Prevention of Postmenopausal Osteoporosis